MedPath

Short Term Outcomes of Laparoscopic Intraperitoneal Onlay Mesh With Facial Repair(IPOM-plus) for Ventral Hernia.

Not Applicable
Completed
Conditions
Hernia
Interventions
Procedure: laparoscopic IPOM hernioplasty with transfacial closure using PDS LOOP 0
Procedure: laparoscopic (IPOM) hernioplasty without repair
Procedure: aparoscopic IIPOM hernioplasty with intracorporeal repair using proline 0 versus stratifix PDS
Registration Number
NCT04137172
Lead Sponsor
Zagazig University
Brief Summary

entral hernias are a major cause of functional impairment, abdominal pain, and bowel obstruction. The overall incidence of primary ventral hernia is estimated to be between 4 and 5 % in the literature, and ventral incisional hernia rates vary from 35 to 60 % within 5 years after laparotomy . After laparoscopy, this rate is estimated to decline from 0.5 to 15 % even after two decades, LVHR or open repair (OVHR) is still a matter of debate because of concerns about seroma formation, recurrence rate, and the intraperitoneal mesh position. . The laparoscopic technique for repairing ventral and incisional hernias is now well established. However, several issues related to LVHR, such as the high recurrence rate of hernias with large fascial defects and in extremely obese patients, are yet to be resolved. Additional problems include seroma formation. To solve these problems, laparoscopic fascial defect closure with IPOM reinforcement (IPOM-Plus) has been introduced in the past decade, and a few studies have reported satisfactory outcomes. Although detailed techniques for fascial defect closure and handling of the mesh have been published, standardized techniques are yet to be established.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
177
Inclusion Criteria
  • patients over 18 years undergoing surgery for primary or incisional ventral hernia
  • defect whose major axis not exceeding 12cm.
Exclusion Criteria
  • Patients undergoing revision
  • Emergency surgery.
  • Parastomal hernias were not included.
  • Patients not candidate for laparoscopy including cardiac and COPD patients

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
group3laparoscopic IPOM hernioplasty with transfacial closure using PDS LOOP 0underwent laparoscopic IPOM hernioplasty with transfacial closure using PDS LOOP 0
group1laparoscopic (IPOM) hernioplasty without repairunderwent laparoscopic IPOM hernioplasty without repair
group2aparoscopic IIPOM hernioplasty with intracorporeal repair using proline 0 versus stratifix PDSunderwent laparoscopic IIPOM hernioplasty with intracorporeal repair using proline 0 versus stratifix PDS
Primary Outcome Measures
NameTimeMethod
post operative complications6 months

Total number of days spent in the hospital. This will be calculated by adding the hospital length of stay for initial surgery, length of stay for any additional readmission resulting from the surgery, and emergency room visits resulting from the surgery

Secondary Outcome Measures
NameTimeMethod
Surgical Site Occurrence (SSO)6 months to one year

Hematoma, seroma, dehiscence, necrosis, non-healing wound found on abdominal exam

Hernia Reoccurence6 months to one year

A hernia that was repaired in the past but has returned

adequacy of different techniques6 months to one year

Surgical Site Infection (SSI) CDC definition

Trial Locations

Locations (1)

Zagazig Unversity

🇪🇬

Zagazig, Egypt

© Copyright 2025. All Rights Reserved by MedPath